Biogelx is engaging experienced business professionals and scientist all over the world to be the first in providing solutions for the key issues on the market.
Douglas is an inspiring and visionary entrepreneur, investor and professional board member with significant commercial acumen and proven ability to contribute at the highest level. He has a track record of leading start-ups to a successful exit. He founded Veterinary Business Development which grew to be one of the largest communications companies in its sector worldwide and was sold to the global corporation Wolters Kluwer in 2000. Douglas currently invests in several early stage companies in a variety of sectors and acts as a non-executive director to several. He is Chairman of BioMedical Business Partners Ltd, IceRobotics Ltd, Virtual Recall Ltd, and Non-Executive Director of Hallmarq Veterinary Imaging Ltd. He is a Fellow of the Royal Society of Edinburgh.
Chief Executive Officer
Mitch is a charismatic leader, and business growth addict, who has successfully driven the commercialisation for a range of technology and services companies within the life sciences sector. Mitch has worked for both large multinationals, SME’s and start-ups including Millipore, Quintiles, Deloitte; Touche, Sartorius Stedim Biotech, Bioprocessors Corporation and Giltech Limited. In his most recent role Mitch led the commercial team at BioOutsource a Glasgow based start-up that was founded in 2007. Over 9 years the company grew from 15 to 180 people and was successfully acquired by Sartorius Stedim Biotech in April 2015.
PROFESSOR REIN ULIJN
Founder and Chief Scientific Officer
Rein is a true champion in an area of nanoscience that focuses on creating materials and systems that are inspired by biology. He has won several awards for his work including the 2013 RSC Norman Heatley Prize, 2013 RSC Emerging Technologies Award and 2007 Macro Group UK Young Researchers Medal. Rein is the founding director of the ASRC’s Nanoscience Initiative at CUNY and is also the Einstein Professor of Chemistry at Hunter College. He gained his MSc degree in Biotechnology at the University of Wageningen (NL), PhD in Physical Chemistry at the University of Strathclyde and postdoctoral training at the University of Edinburgh. From 2003-2008 he was in the School of Materials, University of Manchester.
MHAIRI RODGERS, PhD
Head of Operations
Mhairi is a technical champion in the biotechnology market with experience in 3D biomaterials based on synthetic peptide hydrogels. As a founding Biogelx employee, Mhairi has vast experience and knowledge of our commercial biomaterials. In her current role at Biogelx, Mhairi utilises her skills and experience of the products to oversee and manage company operations. She holds a PhD in Pure and Applied Chemistry from the University of Strathclyde.
LAURA GOLDIE, PhD
Head of Technical Services
Director Strategic Collaborations
Sandy, a qualified pharmacist brings over 30 years’ commercial experience to Biogelx, having worked with several international companies providing both products and services to the biotech community. Sandy has led both operational and multinational commercial teams at several large biotech product and service providers and has a strong track record in delivering on key strategic and collaborative initiatives.
ELIA LOPEZ-BERNARDO, PhD
Global Business Development Manager
Elia is a motivated Business Development professional with broad experience in product commercialization within the 3D cell culture space. Elia holds a PhD in Cellular and Molecular Biology from Universidad Autónoma de Madrid and understands the customer needs in a wide-range of biological applications. She spent two years at Biogelx in New York, heading our US office and successfully driving international sales of our innovative peptide hydrogels. In her current role at Biogelx, Elia manages relationships with biotechnology partners and other industry and academic collaborators to develop and grow our business. Her customer-centric nature always helps to find the best solutions for our clients.